COSMOS Pharmaceutical Corporation (3349.T)

9053.0035.00 (-0.39%)

COSMOS Pharmaceutical Corporation (3349.T) stock comprehensive Cashflow Growth Analysis including operating cash flow, investing cash flow, financing cash flow, free cash flow, cash flow from operations, cash flow from investing, cash flow from financing. Compare cash flow against peers/competitors, industry and sector standards.

Low Bankruptcy RiskLow ProfitabilityEfficient OperationsModerate GrowthModerate QualityAdequate Dividend ProfileIndustry Rank: 67.57%Sector Rank: 75.68%

JPX - Healthcare - Medical - Pharmaceuticals | Market Cap: 717.52B | Next Earnings Date: 14 Oct 2025

Day's Range

8935.00 - 9125.00

52-Week Range

6347.00 - 10045.00

Volume

380.0K / 335.9K (Avg.)

P/E Ratio | EPS

23.15 | 391.09

Trending:

3349.T Cashflow Growth Analysis - Compare Against 2127.T

Comparison against 2127.T

None 3391.T 3141.T 3088.T 2127.T 9843.T

Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.

Net Income Growth

36.95%

Increased from previous period

Net income growth at 50-75% of 2127.T's 49.75%. Martin Whitman would worry about lagging competitiveness unless expansions are planned.

Depreciation & Amortization Growth

No Data

No Data available this quarter, please select a different quarter.

Deferred Income Tax Growth

No Data

No Data available this quarter, please select a different quarter.

Stock-Based Compensation Growth

No Data

No Data available this quarter, please select a different quarter.

Change in Working Capital Growth

No Data

No Data available this quarter, please select a different quarter.

Accounts Receivable Growth

No Data

No Data available this quarter, please select a different quarter.

Inventory Growth

No Data

No Data available this quarter, please select a different quarter.

Accounts Payable Growth

No Data

No Data available this quarter, please select a different quarter.

Other Working Capital Growth

No Data

No Data available this quarter, please select a different quarter.

Other Non-Cash Items Growth

-36.95%

Decreased from previous period

Both negative yoy, with 2127.T at -49.75%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.

CFO Growth (Net Cash from Operations)

No Data

No Data available this quarter, please select a different quarter.

Capital Expenditures Growth

No Data

No Data available this quarter, please select a different quarter.

Acquisitions Growth

No Data

No Data available this quarter, please select a different quarter.

Purchases of Investments Growth

No Data

No Data available this quarter, please select a different quarter.

Sales/Maturities of Investments Growth

No Data

No Data available this quarter, please select a different quarter.

Other Investing Activities Growth

No Data

No Data available this quarter, please select a different quarter.

Net Cash Used in Investing Activities Growth

No Data

No Data available this quarter, please select a different quarter.

Debt Repayment Growth

No Data

No Data available this quarter, please select a different quarter.

Common Stock Issuance Growth

No Data

No Data available this quarter, please select a different quarter.

Stock Repurchase Growth

No Data

No Data available this quarter, please select a different quarter.

Select Chart Metric:

3349.T Cashflow Growth Analysis - Compare Against 2127.T

Comparison against 2127.T

None 3391.T 3141.T 3088.T 2127.T 9843.T

Net Income Growth

36.95%

Increased from previous period

Net income growth at 50-75% of 2127.T's 49.75%. Martin Whitman would worry about lagging competitiveness unless expansions are planned.

Depreciation & Amortization Growth

No Data

No Data available this quarter, please select a different quarter.

Deferred Income Tax Growth

No Data

No Data available this quarter, please select a different quarter.

Stock-Based Compensation Growth

No Data

No Data available this quarter, please select a different quarter.

Change in Working Capital Growth

No Data

No Data available this quarter, please select a different quarter.

Accounts Receivable Growth

No Data

No Data available this quarter, please select a different quarter.

Inventory Growth

No Data

No Data available this quarter, please select a different quarter.

Accounts Payable Growth

No Data

No Data available this quarter, please select a different quarter.

Other Working Capital Growth

No Data

No Data available this quarter, please select a different quarter.

Other Non-Cash Items Growth

-36.95%

Decreased from previous period

Both negative yoy, with 2127.T at -49.75%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.

CFO Growth (Net Cash from Operations)

No Data

No Data available this quarter, please select a different quarter.

Capital Expenditures Growth

No Data

No Data available this quarter, please select a different quarter.

Acquisitions Growth

No Data

No Data available this quarter, please select a different quarter.

Purchases of Investments Growth

No Data

No Data available this quarter, please select a different quarter.

Sales/Maturities of Investments Growth

No Data

No Data available this quarter, please select a different quarter.

Other Investing Activities Growth

No Data

No Data available this quarter, please select a different quarter.

Net Cash Used in Investing Activities Growth

No Data

No Data available this quarter, please select a different quarter.

Debt Repayment Growth

No Data

No Data available this quarter, please select a different quarter.

Common Stock Issuance Growth

No Data

No Data available this quarter, please select a different quarter.

Stock Repurchase Growth

No Data

No Data available this quarter, please select a different quarter.

Select Chart Metric: